Explore 3 Stock Ideas & Industry Insights Download Free Report

Walgreens Boots Alliance Inc.

Company price
None GBX 0.00(0%)
Last update at 2025-09-26T16:00:31.518785Z
Market Cap
23838.55M
P/E
0.04

Momentum Score

…

Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise. The International segment offers sale of prescription drugs and health and wellness, beauty, personal care, and other consumer products outside the United States; and operates pharmacy-led health and beauty retail businesses under the Boots brand stores in the United Kingdom, the Republic of Ireland, and Thailand, as well as the Benavides brand in Mexico and the Ahumada brand in Chile. The U.S. Healthcare segment provides VillageMD, a national provider of value-based care with primary, multi-specialty, and urgent care providers serving patients in traditional clinic settings, in patients' homes and online appointments; Shields, a specialty pharmacy integrator and accelerator for hospitals; and CareCentrix, a participant in the post-acute and home care management sectors. Walgreens Boots Alliance, Inc. was founded in 1909 and is headquartered in Deerfield, Illinois.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

52 Week Price Range
19.67
Low
35.93
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
11.95
Dividend Yield
7.42%
Revenue TTM
139081.01M
Revenue Per Share
161.12
Gross Profit TTM
27072.00M
Debt / Equity
0.37
ROE
-11.98%
Net Debt
-728.00M
ROCE
3.07%
Diluted EPS TTM
7.25

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-08-31 2022-08-31 2021-08-31 2020-08-31 2019-08-31
Type yearly yearly yearly yearly yearly
Date 2023-08-31 2022-08-31 2021-08-31 2020-08-31 2019-08-31
Income before tax -5386.00M 4036.00M 2622.00M 477.00M 4359.00M
Minority interest - - 721.00M 498.00M 641.00M
Net income -3080.00M 4337.00M 1994.00M 179.00M 3982.00M
Selling general administrative 24085.00M 23765.00M 23026.00M 22304.00M 22049.00M
Selling and marketing expenses 775.00M 862.00M 772.00M 532.00M -
Gross profit 27072.00M 28266.00M 28067.00M 26077.00M 28159.00M
Ebit 2212.00M 3639.00M 4269.00M 3241.00M 4976.00M
Ebitda 4098.00M 5322.00M 5958.00M 4868.00M -
Depreciation and amortization 1886.00M 1683.00M 1689.00M 1627.00M -
Operating income 2212.00M 3639.00M 4269.00M 3241.00M 4766.00M
Other operating expenses 143887.00M 128271.00M 129396.00M 120921.00M -
Interest expense - - 0.00M 0.00M 0.00M
Tax provision - - 667.00M 339.00M 577.00M
Interest income - - 499.00M 602.00M 495.00M
Extraordinary items - - 548.00M 277.00M 166.00M
Income tax expense 1858.00M 30.00M 667.00M 339.00M 577.00M
Total revenue 139081.00M 132703.00M 132509.00M 121982.00M 120074.00M
Total operating expenses 31878.00M 23834.00M 24954.00M 25016.00M -
Cost of revenue 112009.00M 104437.00M 104442.00M 95905.00M 91915.00M
Total other income expense net -7598.00M 397.00M -1647.00M -2764.00M -
Discontinued operations - - 548.00M 277.00M 166.00M
Net income applicable to common shares -3080.00M 4337.00M 2542.00M 456.00M 3982.00M
Breakdown 2023-08-31 2022-08-31 2021-08-31 2020-08-31 2019-08-31
Type yearly yearly yearly yearly yearly
Date 2023-08-31 2022-08-31 2021-08-31 2020-08-31 2019-08-31
Total assets 96628.00M 90124.00M 81285.00M 87174.00M 67598.00M
Intangible assets 15135.00M 11830.00M 11036.00M 11672.00M 10876.00M
Other current assets 2226.00M 2160.00M 1899.00M 6677.00M 1118.00M
Total liab 68139.00M 59716.00M 57145.00M 66039.00M 44087.00M
Total stockholder equity 20020.00M 25275.00M 23419.00M 20637.00M 23511.00M
Other current liab 11900.00M 11328.00M 10918.00M 16925.00M 222.00M
Common stock 12.00M 12.00M 12.00M 12.00M 12.00M
Retained earnings 33058.00M 37801.00M 35121.00M 34210.00M 35815.00M
Other liab 12416.00M 4102.00M 4266.00M 3965.00M 6578.00M
Good will 28187.00M 22280.00M 12421.00M 12013.00M 16560.00M
Other assets 2524.00M 1646.00M 1986.00M 5547.00M 1060.00M
Cash 728.00M 1358.00M 559.00M 469.00M 1023.00M
Total current liabilities 24535.00M 22583.00M 22054.00M 27070.00M 25769.00M
Net debt -728.00M -1358.00M -559.00M -469.00M -
Short term debt - - - 1517.00M 2400.00M
Short long term debt total - - 8649.00M 13223.00M 11098.00M
Other stockholder equity -13050.00M -12538.00M -11714.00M -13585.00M -3897.00M
Property plant equipment 31754.00M 31301.00M 32738.00M 32588.00M 12208.00M
Total current assets 15503.00M 16902.00M 15814.00M 18073.00M 18700.00M
Net tangible assets -23302.00M -9422.00M -340.00M -3109.00M -5194.00M
Short term investments 11.00M 1114.00M 634.00M - -
Net receivables 4281.00M 3917.00M 4563.00M 3010.00M 7226.00M
Long term debt - - 7675.00M 12203.00M 11098.00M
Inventory 8257.00M 8353.00M 8159.00M 7917.00M 9333.00M
Accounts payable 12635.00M 11255.00M 11136.00M 10145.00M 14341.00M
Treasury stock - - -20593.00M -20575.00M -19057.00M
Non currrent assets other -78601.00M -71576.00M -63485.00M -63554.00M -
Non current assets total 78601.00M 71576.00M 63485.00M 63554.00M -
Breakdown 2023-08-31 2022-08-31 2021-08-31 2020-08-31 2019-08-31
Type yearly yearly yearly yearly yearly
Date 2023-08-31 2022-08-31 2021-08-31 2020-08-31 2019-08-31
Change to liabilities 1243.00M 244.00M 842.00M -25.00M 954.00M
Total cashflows from investing activities -3094.00M -1064.00M 4072.00M -1297.00M -2307.00M
Net borrowings -2703.00M 1996.00M -7127.00M -1208.00M 2508.00M
Total cash from financing activities -887.00M -1499.00M -9036.00M -4647.00M -3047.00M
Change to operating activities 5401.00M -73.00M 712.00M 961.00M -640.00M
Net income -3080.00M 4337.00M 2542.00M 456.00M 3982.00M
Change in cash -1702.00M 1288.00M 524.00M -461.00M 232.00M
Begin period cash flow 2558.00M 1270.00M 746.00M 1207.00M -
End period cash flow 856.00M 2558.00M 1270.00M 746.00M 1207.00M
Total cash from operating activities 2258.00M 3899.00M 5555.00M 5484.00M 5594.00M
Depreciation 1886.00M 1683.00M 1689.00M 1627.00M 1778.00M
Other cashflows from investing activities 6336.00M 2859.00M 1355.00M 795.00M 136.00M
Dividends paid 1659.00M 1659.00M 1617.00M 1747.00M 1643.00M
Change to inventory 287.00M -433.00M 165.00M 63.00M 141.00M
Change to account receivables 72.00M 808.00M -1451.00M 163.00M -789.00M
Sale purchase of stock -150.00M -187.00M -110.00M -1589.00M -3986.00M
Other cashflows from financing activities 9900.00M 10298.00M 11635.00M 20103.00M 74.00M
Change to netincome -4363.00M -2923.00M 612.00M 2160.00M 314.00M
Capital expenditures 2117.00M 1734.00M 1379.00M 1374.00M 1702.00M
Change in working capital 359.00M 375.00M -1286.00M 226.00M -739.00M
Stock based compensation 385.00M 391.00M 155.00M 137.00M -
Other non cash items 2708.00M -2887.00M 2455.00M 3038.00M -
Free cash flow 141.00M 2165.00M 4176.00M 4110.00M -

Peer Comparison*

Sector: Industry:

Stock Name
Change
(GBX)
Price
(GBX)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
0R15
SoftBank Group Corp.
248.00
5.84%
4494.00 - - - -
0R1E
Nintendo Co. Ltd.
-115.00
1.34%
8476.00 - - - -
0LC3
Synchrony Financial
2.34
3.20%
75.60 0.09 - 4.97 -
0HQP
CBRE Group Inc. Cl A
0.15
0.12%
122.47 0.25 - 1.18 -

Profile*

Walgreens Boots Alliance Inc.

Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise. The International segment offers sale of prescription drugs and health and wellness, beauty, personal care, and other consumer products outside the United States; and operates pharmacy-led health and beauty retail businesses under the Boots brand stores in the United Kingdom, the Republic of Ireland, and Thailand, as well as the Benavides brand in Mexico and the Ahumada brand in Chile. The U.S. Healthcare segment provides VillageMD, a national provider of value-based care with primary, multi-specialty, and urgent care providers serving patients in traditional clinic settings, in patients' homes and online appointments; Shields, a specialty pharmacy integrator and accelerator for hospitals; and CareCentrix, a participant in the post-acute and home care management sectors. Walgreens Boots Alliance, Inc. was founded in 1909 and is headquartered in Deerfield, Illinois.

108 Wilmot Road, Deerfield, IL, United States, 60015

847 315 3700

206000

Name Title Year Born
Mr. Stefano Pessina Exec. Chairman 1941
Ms. Rosalind Gates Brewer CEO & Director 1962
Mr. James Kehoe Exec. VP & Global CFO 1962
Ms. Ornella Barra Chief Operating Officer of International 1953
Mr. Hsiao Wang Sr. VP & Chief Information Officer 1973
Mr. Gerald Gradwell Sr. VP of Investor Relations 1968
Ms. Danielle Carim Gray Exec. VP & Global Chief Legal Officer 1979
Mr. Aaron C. Radelet Global Chief Communications Officer & Sr. VP NA
Ms. Holly May Exec. VP & Global Chief HR Officer 1982
Ms. Mia M. Scholz Sr. VP of Corp. Financial Operations 1966

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…